Alba Romero-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alba Romero-Rodríguez has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
S. Sánchez
Laboratorio de Microbiología Industrial. Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico
2 shared publications- Adán Alcántara Reyes
Biologia Molecular y Biotecnologia, Universidad Nacional Autónoma de México, Mexico City, Mexico, Mexico
1 shared publication - Albert D. Patiño
Departametno de Framacia, Universidad Nacional Autónoma de México, Mexico City, Mexico, Mexico
1 shared publication B. Ruíz-Villafán
Laboratorio de Microbiología Industrial. Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico
1 shared publication- Beatriz Ruiz-Villafán
Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico
1 shared publication C. Guzmán
Posgrado en Microbiología, Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Ciudad Universitaria, Puebla, Puebla, 72592, Mexico
1 shared publication
Latest Publications
- Open Access
- 7 July 2026
- Published by MDPI AG in Preprints.org
Culturable Fungi Recovered from Fecal Samples of Hospitalized Patients with Nosocomial Diarrhea: Isolation, Phenotypic Characterization, and Metabolomic Profiling
Fungi recovered from human fecal samples represent an understudied component of the gastrointestinal microbiome, yet fungi can play important roles in health and disease, particularly in hospitalized and immunocompromised patients. Here, we report the culture-based characterization of fungi isolated from fecal samples of 39 hospitalized patients with nosocomial diarrhea in Mexico City. Fungal growth was observed in approximately 40% of samples, yielding 26 isolates: 20 yeasts and 6 filamentous fungi. The predominant genera were Candida (mainly C. albicans) and Rhodotorula, with less common species including Nakaseomyces glabratus, Lodderomyces elongisporus, and yeasts previously explored for probiotic applications, Meyerozyma and Metschnikowia spp. Among filamentous fungi, Paecilomyces variotii and multiple Penicillium species were identified. Phenotypic assays demonstrated that several yeast isolates tolerated gut-associated stress conditions, including elevated temperature, bile salts, and oxidative stress, while thermotolerant filamentous fungi remained viable at temperatures up to 42°C. Cell-free supernatants and organic extracts of selected thermotolerant filamentous fungi showed moderate cytotoxic activity against non-differentiated Caco-2 cells.
- 7 July 2026
- Published by MDPI AG in Preprints.org
Open AccessCulturable Fungi Recovered from Fecal Samples of Hospitalized Patients with Nosocomial Diarrhea: Isolation, Phenotypic Characterization, and Metabolomic Profiling
Fungi recovered from human fecal samples represent an understudied component of the gastrointestinal microbiome, yet fungi can play important roles in health and disease, particularly in hospitalized and immunocompromised patients. Here, we report the culture-based characterization of fungi isolated from fecal samples of 39 hospitalized patients with nosocomial diarrhea in Mexico City. Fungal growth was observed in approximately 40% of samples, yielding 26 isolates: 20 yeasts and 6 filamentous fungi. The predominant genera were Candida (mainly C. albicans) and Rhodotorula, with less common species including Nakaseomyces glabratus, Lodderomyces elongisporus, and yeasts previously explored for probiotic applications, Meyerozyma and Metschnikowia spp. Among filamentous fungi, Paecilomyces variotii and multiple Penicillium species were identified. Phenotypic assays demonstrated that several yeast isolates tolerated gut-associated stress conditions, including elevated temperature, bile salts, and oxidative stress, while thermotolerant filamentous fungi remained viable at temperatures up to 42°C. Cell-free supernatants and organic extracts of selected thermotolerant filamentous fungi showed moderate cytotoxic activity against non-differentiated Caco-2 cells.
- Open Access
- 10 August 2024
- Published by Elsevier in Microbiological Research
- Vol. 288, 127870
Is there a role for intestinal sporobiota in the antimicrobial resistance crisis?
- 10 August 2024
- Published by Elsevier in Microbiological Research
- Vol. 288, 127870
Open AccessIs there a role for intestinal sporobiota in the antimicrobial resistance crisis?
- Open Access
- 9 March 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1176453
Editorial: Mechanism of colonization and persistence of gut commensal microbiota and pathogens
Editorial: Mechanism of colonization and persistence of gut commensal microbiota and pathogens
- 9 March 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1176453
Open AccessEditorial: Mechanism of colonization and persistence of gut commensal microbiota and pathogens
Editorial: Mechanism of colonization and persistence of gut commensal microbiota and pathogens
- Open Access
- 26 January 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (2) , 248
Targeting the Impossible: A Review of New Strategies against Endospores
Endospore-forming bacteria are ubiquitous, and their endospores can be present in food, in domestic animals, and on contaminated surfaces. Many spore-forming bacteria have been used in biotechnological applications, while others are human pathogens responsible for a wide range of critical clinical infections. Due to their resistant properties, it is challenging to eliminate spores and avoid the reactivation of latent spores that may lead to active infections. Furthermore, endospores play an essential role in the survival, transmission, and pathogenesis of some harmful strains that put human and animal health at risk. Thus, different methods have been applied for their eradication. Nevertheless, natural products are still a significant source for discovering and developing new antibiotics. Moreover, targeting the spore for clinical pathogens such as Clostridioides difficile is essential to disease prevention and therapeutics. These strategies could directly aim at the structural components of the spore or their germination process. This work summarizes the current advances in upcoming strategies and the development of natural products against endospores. This review also intends to highlight future perspectives in research and applications.
- 26 January 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (2) , 248
Open AccessTargeting the Impossible: A Review of New Strategies against Endospores
Endospore-forming bacteria are ubiquitous, and their endospores can be present in food, in domestic animals, and on contaminated surfaces. Many spore-forming bacteria have been used in biotechnological applications, while others are human pathogens responsible for a wide range of critical clinical infections. Due to their resistant properties, it is challenging to eliminate spores and avoid the reactivation of latent spores that may lead to active infections. Furthermore, endospores play an essential role in the survival, transmission, and pathogenesis of some harmful strains that put human and animal health at risk. Thus, different methods have been applied for their eradication. Nevertheless, natural products are still a significant source for discovering and developing new antibiotics. Moreover, targeting the spore for clinical pathogens such as Clostridioides difficile is essential to disease prevention and therapeutics. These strategies could directly aim at the structural components of the spore or their germination process. This work summarizes the current advances in upcoming strategies and the development of natural products against endospores. This review also intends to highlight future perspectives in research and applications.